SCHEDULE 13D/A: Perceptive Funds Disclose 19.8% Beneficial Stake in Trinity Biotech plc, Including Warrants

Perceptive Advisors LLC and its affiliated entities have filed an Amendment No. 4 to their Schedule 13D, disclosing a combined beneficial ownership of 19.8% in Trinity Biotech plc, including exercisable warrants.

Summary

• Perceptive Advisors LLC, Perceptive Credit Advisors LLC, Joseph Edelman, Perceptive Credit Holdings II, L.P., and Perceptive Credit Holdings III, L.P. collectively beneficially own 85,800,000 Class A Ordinary Shares of Trinity Biotech plc.
• This aggregate ownership represents 19.8% of Trinity Biotech plc's outstanding Class A Ordinary Shares.
• The reported beneficial ownership includes warrants held by the Reporting Persons for an aggregate of 50,000,000 Ordinary Shares.
• Specifically, Perceptive Credit Holdings II, L.P. holds warrants for 10,000,000 Ordinary Shares (represented by 500,000 ADSs).
• Perceptive Credit Holdings III, L.P. holds warrants for 40,000,000 Ordinary Shares (represented by 2,000,000 ADSs).
• The percentage of class is calculated based on 383,881,600 Ordinary Shares outstanding as of March 15, 2025, as reported in Trinity Biotech's Form F-3 registration statement.

Sentiment

Score: 5

Explanation: The document is a factual disclosure of beneficial ownership and does not contain information that inherently suggests positive or negative sentiment regarding the company's performance or outlook. It is a neutral, regulatory update.

Risks

• The warrants held by the Reporting Persons may not be exercised if, after giving effect to such exercise, the Reporting Persons would beneficially own more than 9.99% of the Issuer's outstanding Ordinary Shares.

Future Outlook

NA

Industry Context

This filing is a standard disclosure of significant beneficial ownership by an investment firm in a publicly traded company within the healthcare or diagnostics sector (Trinity Biotech plc). Such disclosures are common and reflect investment positions rather than operational or strategic shifts within the industry.

Stakeholder Impact

• Shareholders: The disclosure of a significant beneficial ownership stake by an investment firm like Perceptive can influence investor perception and potentially the stock's trading dynamics due to the large block of shares held and the potential for future actions by the beneficial owner.

Key Dates

Keywords

Trinity Biotech plc, Perceptive Advisors, Schedule 13D, Beneficial Ownership, Warrants, Class A Ordinary Shares, Investment Firm, SEC Filing